ECE2008 Poster Presentations Diabetes and cardiovascular diseases (90 abstracts)
Diabetes management and metabolic control are below expectations in specialist diabetes practice in Portugal
Salvador Massano Cardoso , Rui Duarte , José Manuel Boavida , Carvalheiro Manuela , Carvalho Davide & Gardete Luís
Sociedade Portuguesa de Diabetologia, Lisbon, Portugal.
In Portugal, no relevant epidemiologic data exists relative to the management and level of control of diabetic patients.
TEDDI, a non-interventional cross-sectional study, allowed to characterize the usual management of type 1 (T1D) and type 2 (T2D) diabetes using a standardized questionnaire in 1775 patients (F: 47.5%; T2D: 80.8%) aged 18 years or older, visiting their diabetes specialist (n=180).
Data was obtained for metabolic control and risk factor prevalence. Main results are as follows (CI 95%):
| n | HTN, % | High LDL, % | Low HDL, % | High TGs, % | non-FBG, mg/dl | HbA1c, % |
| T1D, 336 | 29.9 (25.2–35.0) | 30.8 (26.0–36.0) | 36.6 (31.5–42.0) | 16.5 (12.9–20.9) | 176.4 (±85.9) | 8.0 (±1.7) |
| T2D, 1395 | 70.1 (67.7–72.4) | 51.2 (48.5–53.9) | 40.6 (38.0–43.3) | 35.0 (32.5–37.5) | 183.7 (±73.0) | 7.6 (±1.5) |
Severe hypoglycaemic crises (requiring emergency care) were reported by 3.4% of patients (T1D: 7.5%; T2D: 2.3%) in the preceding month. In these, an average of 2.4 crises per patient was determined.
In T2D, level of insulinization was 47.0%, and 31% were treated simultaneously with oral hypoglycaemic, antihypertensive, antidyslipidemic and anti-platelet drugs. In T1D, 16.1% of patients used LA insulin, while metformin was used as an adjuvant therapy in 15.2%.
Although old barriers in diabetes management (insulin for T2D and LA insulin and metformin for T1D) are overcome, metabolic control is still below expectations.
Article tools
My recent searches
My recently viewed abstracts
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more